Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Journal of Chromatography|August 13, 1982
Determination of the anticoagulant phenprocoumon in human plasma and urine by high-performance liquid chromatographyJ X De Vries, J Harenberg, E Walter, et al.
Thrombosis Research|April 1, 1985
Inhibition of low molecular weight heparin by protamine chloride in vivoJ Harenberg, A Gnasso, J X de Vries, et al.
Klinische Wochenschrift|February 15, 1988
Benzbromarone disposition and uricosuric action; evidence for hydroxilation instead of debromination to benzaroneI Walter-Sack, J X de Vries, A Ittensohn, et al.
European Journal of Clinical Pharmacology|January 1, 1995
Disposition and uric acid lowering effect of oxipurinol: comparison of different oxipurinol formulations and allopurinol in healthy individualsI Walter-Sack, J X de Vries, C Kutschker, et al.
European Journal of Medical Research|May 28, 1997
Fasting and postprandial disposition of R(-)- and S(+)-ibuprofen following oral administration of racemic drug in healthy individualsD Siemon, J X de Vries, F Stötzer, et al.
European Journal of Clinical Pharmacology|January 1, 1988
Biliary excretion of phenprocoumon and metabolitesJ X de Vries, R Raedsch, U Völker, et al.
Journal of Chromatography|October 31, 1986
Determination of benzarone in human plasma and urine by high-performance liquid chromatography and gas chromatography-mass spectrometry. Identification of the conjugatesJ X de Vries, I Walter-Sack, A van de Loo, et al.
Klinische Wochenschrift|March 1, 1985
The effects of a combination of cigarette smoking and oral contraception on coagulation and fibrinolysis in human femalesJ Harenberg, C Staiger, J X de Vries, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|November 1, 1989
The influence of different formula diets and different pharmaceutical formulations on the systemic availability of paracetamol, gallbladder size, and plasma glucoseI E Walter-Sack, J X de Vries, B Nickel, et al.
European Journal of Medical Research|October 16, 1995
Biotransformation and uric acid lowering effect of benzbromarone in patients with liver cirrhosis - evidence for active benzbromarone metabolites?I Walter-Sack, J X de Vries, A von Bubnoff, et al.
Pageof 5